I agree that this site is using cookies. You can find further informations here.
X
Le Gars, Mathieu
74  results:
Search for persons X
?
1

Safety, reactogenicity, and immunogenicity of Ad26.COV2.S a..:

Le Gars, Mathieu ; Sadoff, Jerald ; Cárdenas, Vicky...
Vaccine.  42 (2024)  19 - p. 3938-3952 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Safety and immunogenicity of Ad26.COV2.S in adults: A rando..:

Cárdenas, Vicky ; Le Gars, Mathieu ; Truyers, Carla...
Vaccine.  42 (2024)  16 - p. 3536-3546 , 2024
Link: https://doi.org/10.1016/..
 
?
3

B cell somatic hypermutation following COVID-19 vaccination..:

Jacob-Dolan, Catherine ; Lifton, Michelle ; Powers, Olivia C....
iScience.  27 (2024)  5 - p. 109716 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Quantifying how single dose Ad26.COV2.S vaccine efficacy de..:

Magaret, Craig A. ; Li, Li ; deCamp, Allan C....
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
5

Comparative analysis of spike-specific IgG Fc glycoprofiles..:

Van Coillie, Julie ; Pongracz, Tamas ; Šuštić, Tonći...
iScience.  26 (2023)  9 - p. 107619 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Mechanistic modeling projections of antibody persistence af..:

Dari, Anna ; Jacqmin, Philippe ; Iwaki, Yuki...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  10 - p. 1485-1498 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Safety, reactogenicity, and immunogenicity of Ad26.COV2.S: ..:

Tsuchiya, Yumi ; Tamura, Hiroshi ; Fujii, Koji...
Vaccine.  41 (2023)  9 - p. 1602-1610 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Durable antibody responses elicited by 1 dose of Ad26.COV2...:

Sadoff, Jerald ; Le Gars, Mathieu ; Brandenburg, Boerries...
Vaccine.  40 (2022)  32 - p. 4403-4411 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Efficacy, safety, and immunogenicity of a booster regimen o..:

Hardt, Karin ; Vandebosch, An ; Sadoff, Jerald...
The Lancet Infectious Diseases.  22 (2022)  12 - p. 1703-1715 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Immune correlates analysis of the ENSEMBLE single Ad26.COV2..:

Fong, Youyi ; McDermott, Adrian B. ; Benkeser, David...
Nature Microbiology.  7 (2022)  12 - p. 1996-2010 , 2022
Link: https://doi.org/10.1038/..
 
?
11

Safety and immunogenicity of 3 formulations of a Sabin inac..:

Ong-Lim, Anna Lisa ; Shukarev, Georgi ; Trinidad-Aseron, Mitzi...
Human Vaccines & Immunotherapeutics.  18 (2022)  5 - p. , 2022
Link: https://doi.org/10.1080/..
 
?
12

Quantifying Antibody Persistence After a Single Dose of COV..:

Dari, Anna ; Boulton, Muriel ; Neyens, Martine...
Clinical Pharmacology & Therapeutics.  113 (2022)  2 - p. 380-389 , 2022
Link: https://doi.org/10.1002/..
 
?
13

Passive transfer of Ad26.COV2.S-elicited IgG from humans at..:

Tostanoski, Lisa H. ; Chandrashekar, Abishek ; Patel, Shivani...
npj Vaccines.  7 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
14

Impact of Preexisting Anti–Adenovirus 26 Humoral Immunity o..:

Le Gars, Mathieu ; Sadoff, Jerald ; Struyf, Frank...
The Journal of Infectious Diseases.  226 (2022)  6 - p. 979-982 , 2022
Link: https://doi.org/10.1093/..
 
?
15

Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral v..:

Le Gars, Mathieu ; Hendriks, Jenny ; Sadoff, Jerald...
Immunological Reviews.  310 (2022)  1 - p. 47-60 , 2022
Link: https://doi.org/10.1111/..
 
1-15